A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss

Completed · Phase 3 · Has a placebo group

Conditions studied: Androgenetic Alopecia

In brief

The primary purpose of the study is to evaluate the efficacy of a topical 5% minoxidil formulation in males for the treatment of pattern hair loss. The secondary purpose is to evaluate the safety of a topical 5% minoxidil formulation in males when used twice daily for the treatment of pattern hair loss and to obtain the safety data on the investigational product when used twice daily for up to one year.

Key facts

Study ID

NCT00151515

Run by

Johnson & Johnson Consumer and Personal Products Worldwide

People needed

352

Starts

2003-10-01

Expected to finish

2004-07-01

Last updated by the study team

2016-09-30

Who can join

Age: 15 and older, up to 49. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• presence of androgenetic alopecia with vertex pattern IIIv, IV, or V on the Norwood Hamilton Scale
• Male sex, age 15 to 49, good health
• Willingness to have a dot tattoo placed in the target area of the scalp during the study
• Willingness to maintain normal shampooing habits and products during the study
• Willingness to maintain the same hair style, approximate length, and hair color throughout the study

You may not qualify if…

• Known sensitivity to the investigational product

Where it is running

• Pfizer Investigational Site — La Jolla, California, United States
• Pfizer Investigational Site — San Francisco, California, United States
• Pfizer Investigational Site — Vallejo, California, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — New Haven, Connecticut, United States
• Pfizer Investigational Site — Fridley, Minnesota, United States
• Pfizer Investigational Site — Minneapolis, Minnesota, United States
• Pfizer Investigational Site — Durham, North Carolina, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — Cleveland, Ohio, United States
• Pfizer Investigational Site — Portland, Oregon, United States
• Pfizer Investigational Site — Hershey, Pennsylvania, United States
• Pfizer Investigational Site — Austin, Texas, United States
• Pfizer Investigational Site — Dallas, Texas, United States
• Pfizer Investigational Site — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.